| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 86851 |
p-NH2-Bn-DOTA-四叔丁酯 |
113 |
zyl |
2024-11-21 |
| 86852 |
CAS号：213187-44-1 DOTA-BIM-23014:DOTA-Lanreotide |
111 |
zyl |
2024-11-21 |
| 86853 |
1,4,7,10-tetraazacyclododecane-N,N′,N″,N‴-tetraacetic acid-lanreotide 定制 |
88 |
zcy |
2024-11-21 |
| 86854 |
DOTA-cyclo(RGDfK) acetate |
85 |
zyl |
2024-11-21 |
| 86855 |
NHS-DOTA 齐岳供应 |
111 |
zcy |
2024-11-21 |
| 86856 |
叠氮-PEG-氨基（N3-PEG-NH2） |
173 |
WYQ |
2024-11-21 |
| 86857 |
CAS号：149819-85-2，Iron DOTA Sodium Salt |
92 |
zyl |
2024-11-21 |
| 86858 |
叠氮化的5,10,15,20四苯基卟啉（PPN3） |
144 |
WYQ |
2024-11-21 |
| 86859 |
金属螯合剂DOTA Acrylamide |
153 |
kx |
2024-11-21 |
| 86860 |
双(2-叠氮基乙基)3,3'-(丙烷-2,2-二基双(硫代二烷基))二丙酸酯（TK-N3） |
95 |
WYQ |
2024-11-21 |
| 86861 |
DOTA-PEG48-Cys-VS DOTA修饰的单分散PEG结合的巯基化双抗体 |
128 |
zcy |
2024-11-21 |
| 86862 |
炔基功能化的聚谷氨酸(PPLG) |
146 |
WYQ |
2024-11-21 |
| 86863 |
两亲性分子寡聚苯撑乙炔衍生物OPE-PEG-NH2 |
118 |
WYQ |
2024-11-21 |
| 86864 |
DOTA-ACA，DOTA-丙烯酰胺，DOTA-Acrylamide |
97 |
kx |
2024-11-21 |
| 86865 |
DOTA-(His)2-minigastrin 科研定制 |
87 |
zcy |
2024-11-21 |
| 86866 |
DOTA-(His)2-minigastrin 科研定制 |
93 |
zcy |
2024-11-21 |
| 86867 |
叠氮修饰的三嵌段聚合物PEG-b-P(BIEM-N3)-b-PtBA |
268 |
WYQ |
2024-11-21 |
| 86868 |
DOTA-(Tyr3)-Octreotate |
143 |
kx |
2024-11-21 |
| 86869 |
DOTA-PP-F11N DOTA-(dGlu) 齐岳供应 |
96 |
zcy |
2024-11-21 |
| 86870 |
DOTA-E[c(RGDfK)2],DOTA-Glu(cyclo(Arg-Gly-Asp-DPhe-Lys) |
92 |
kx |
2024-11-21 |
| 86871 |
753421-63-5，DOTA-C4-NH2 |
93 |
kx |
2024-11-21 |
| 86872 |
Ga-DOTA-TOC acetate，CAS号：293295-70-2 |
123 |
zyl |
2024-11-21 |
| 86873 |
DOTA-D-Tat peptide stock solution (3 mM) 齐岳供应 |
100 |
zcy |
2024-11-21 |
| 86874 |
DOTA-Acrylamide,DOTA-DBCO,DOTA-MeTz |
98 |
kx |
2024-11-21 |
| 86875 |
DOTA-Knottin Peptide 齐岳定制 |
112 |
zcy |
2024-11-21 |
| 86876 |
DOTA-RGD,DOTA多肽衍生物 |
137 |
kx |
2024-11-21 |
| 86877 |
DOTA-Nal3-Octreotide DOTANOC DOTA-Nal3-奥曲肽 |
109 |
zcy |
2024-11-21 |
| 86878 |
DOTA-丙烯酰胺,DOTA Acrylamide |
102 |
kx |
2024-11-21 |
| 86879 |
DOTA Tris-(t-butyl ester) Ethylenediamino Monoamide |
102 |
zyl |
2024-11-21 |
| 86880 |
1262403-91-7,七肽DOTA-YLYEIAR,螯合物前体肽 |
96 |
kx |
2024-11-21 |
| 86881 |
DOTA-8-AOC-BBN (7-14)NH2 NOTA-共轭铃蟾肽衍生物 |
102 |
zcy |
2024-11-21 |
| 86882 |
多叠氮基聚乙二醇衍生物(PEGn(N3))m |
93 |
WYQ |
2024-11-21 |
| 86883 |
DOTA derivative，CAS号：153777-70-9 |
87 |
zyl |
2024-11-21 |
| 86884 |
多炔基聚乙二醇衍生物(PEGn(C≡CH))m |
132 |
WYQ |
2024-11-21 |
| 86885 |
173308-19-5,DOTA-(COOt-Bu)3-C2-NH2 |
85 |
kx |
2024-11-21 |
| 86886 |
DOTA-ADIBO，CAS号：1374865-01-6 |
90 |
zyl |
2024-11-21 |
| 86887 |
端炔基聚乙二醇（PEG-alk） |
174 |
WYQ |
2024-11-21 |
| 86888 |
Gd-DOTA-HCBP(多肽核磁共振成像(MRI)探针) |
100 |
zyl |
2024-11-21 |
| 86889 |
NOTA-IPB-PDL1P PET成像分子探针 |
96 |
zcy |
2024-11-21 |
| 86890 |
DOTA大环化合物,Tm-DOTA,CAS号78063-83-9 |
101 |
zyl |
2024-11-21 |
| 86891 |
DOTA-E[c(RGDyK)2],金属离子螯合剂 |
104 |
kx |
2024-11-21 |
| 86892 |
DOTA-8-AOC-BOMBESIN(7-14)NH2 DOTA-8-AOC-铃蟾肽(7-14)氨基 |
94 |
zcy |
2024-11-21 |
| 86893 |
DOTA-Arg-Gly-Asp-Ser-Pro-Lys-COOH |
134 |
kx |
2024-11-21 |
| 86894 |
GGG-PEG4-DOTA |
84 |
zyl |
2024-11-21 |
| 86895 |
叠氮化四乙酰基葡萄糖（TAGP-N3） |
106 |
WYQ |
2024-11-21 |
齐岳微信公众号
官方微信
库存查询